IP Library Granted Patent US 8,646,617
Granted Patent B2
US 8,646,617 · App. 13/951,239 · Granted Feb 11, 2014

Reverse osmosis membrane having good antifouling properties and method of manufacturing the same

Inventors: Seung-Pyo Jeong (Daejeon, KR); Chong-Kyu Shin (Daejeon, KR)
Assignee: LG Chem, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,646,617
App. No.
13/951,239
Granted
Feb 11, 2014
Kind
B2
Abstract

A reverse osmosis membrane includes a porous support, a polyamide active layer formed on the porous support, and a coating layer including a copolymer including an amphoteric ionic compound and glycidyl (meth)acrylate. The coating layer makes a chemical bond with the polyamide active layer. A method of manufacturing the reverse osmosis membrane also is disclosed.

Claims (23)

1. A reverse osmosis membrane, comprising:

a porous support;

a polyamide active layer formed on the porous support; and a coating layer including a copolymer including an amphoteric ionic compound and a glycidyl (meth)acrylate, the coating layer making a chemical bond with the polyamide active layer; wherein the amphoteric ionic compound comprises one or more groups selected from the groups consisting of an ammonium group, a phosphonium group, a sulfonic acid group, a phosphate group and an acetate group.

2. The reverse osmosis membrane of claim 1 , wherein the amphoteric ionic compound is a compound represented by following Chemical Formula 1 or a compound represented by following Chemical Formula 2,

in Chemical Formulae 1 and 2, R 1 represents H or a C 1-10 alkyl group,

R 2 represents O, NH, S or PH,

each of R 3 , R 4 , R 5 , R 6 and R 7 independently represents hydrogen or a C 2-5 alkyl group,

n 1 represents an integer of 1 to 8, and

n 2 represents an integer of 1 to 4.

3. The reverse osmosis membrane of claim 1 , wherein the amphoteric ionic compound is at least one selected from the group consisting of [2-(methacrylolyloxy)ethyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [2-(methacrylolyloxy)ethyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [2-(methacrylolyloxy)ethyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [2-(methacrylolyloxy)ethyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [2-(acryloyloxy)ethyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [2-(acryloyloxy)ethyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [2-(acryloyloxy)ethyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [2-(acryloyloxy)ethyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [3-(methacrylolyloxy)propyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [3-(methacrylolyloxy)propyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [3-(methacrylolyloxy)propyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [3-(methacrylolyloxy)propyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [3-(acryloyloxy)propyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [3-(acryloyloxy)propyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [3-(acryloyloxy)propyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [3-(acryloyloxy)propyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [4-(methacrylolyloxy)butyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [4-(methacrylolyloxy)butyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [4-(methacrylolyloxy)butyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [4-(methacrylolyloxy)butyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [4-(methacrylolyloxy)butyl]-dimethyl-(6-sulfohexyl)-ammonium hydroxide, [4-(acryloyloxy)butyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [4-(acryloyloxy)butyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [4-(acryloyloxy)butyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [4-(acryloyloxy)butyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [4-(acryloyloxy)butyl]-dimethyl-(6-sulfohexyl)-ammonium hydroxide, [2-(methacrylolylamino)ethyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [2-(methacrylolylamino)ethyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [2-(methacrylolylamino)ethyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [2-(methacrylolylamino)ethyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [2-(acryloylamino)ethyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [2-(acryloylamino)ethyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [2-(acryloylamino)ethyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [2-(acryloylamino)ethyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [3-(methacrylolylamino)propyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [3-(methacrylolylamino)propyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [3-(methacrylolylamino)propyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [3-(methacrylolylamino)propyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [3-(acryloylamino)propyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [3-(acryloylamino)propyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [3-(acryloylamino)propyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [3-(acryloylamino)propyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [4-(methacrylolylamino)butyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [4-(methacrylolylamino)butyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [4-(methacrylolylamino)butyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [4-(methacrylolylamino)butyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [4-(methacrylolylamino)butyl]-dimethyl-(6-sulfohexyl)-ammonium hydroxide, [4-(acryloylamino)butyl]-dimethyl-(2-sulfoethyl)-ammonium hydroxide, [4-(acryloylamino)butyl]-dimethyl-(3-sulfopropyl)-ammonium hydroxide, [4-(acryloylamino)butyl]-dimethyl-(4-sulfobutyl)-ammonium hydroxide, [4-(acryloylamino)butyl]-dimethyl-(5-sulfopentyl)-ammonium hydroxide, [4-(acryloylamino)butyl]-dimethyl-(6-sulfohexyl)-ammonium hydroxide, 2-(methacrylolyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, 3-(methacrylolyloxy)propyl 2-(trimethylammonio)ethyl phosphate, 4-(methacrylolyloxy)butyl 2-(trimethylammonio)ethyl phosphate, 5-(methacrylolyloxy)pentyl 2-(trimethylammonio)ethyl phosphate, 6-(methacrylolyloxy)hexyl 2-(trimethylammonio)ethyl phosphate, 7-(methacrylolyloxy)heptyl 2-(trimethylammonio)ethyl phosphate, 8-(methacrylolyloxy)octyl 2-(trimethylammonio)ethyl phosphate, 2-(methacrylolylamino)ethyl 2-(trimethylammonio)ethyl phosphate, 3-(methacrylolylamino)propyl 2-(trimethylammonio)ethyl phosphate, 4-(methacrylolylamino)butyl 2-(trimethylammonio)ethyl phosphate, 5-(methacrylolylamino)pentyl 2-(trimethylammonio)ethyl phosphate, 6-(methacrylolylamino)hexyl 2-(trimethylammonio)ethyl phosphate, 7-(methacrylolylamino)heptyl 2-(trimethylammonio)ethyl phosphate, 8-(methacrylolylamino)octyl 2-(trimethylammonio)ethyl phosphate, 2-(acryloyloxy)ethyl 2-(trimethylammonio)ethyl phosphate, 3-(acryloyloxy)propyl 2-(trimethylammonio)ethyl phosphate, 4-(acryloyloxy)butyl 2-(trimethylammonio)ethyl phosphate, 5-(acryloyloxy)pentyl 2-(trimethylammonio)ethyl phosphate, 6-(acryloyloxy)hexyl 2-(trimethylammonio)ethyl phosphate, 7-(acryloyloxy)heptyl 2-(trimethylammonio)ethyl phosphate, 8-(acryloyloxy)octyl 2-(trimethylammonio)ethyl phosphate, 2-(methacrylolyloxy)ethyl 3-(trimethylammonio)propyl phosphate, 3-(methacrylolyloxy)propyl 3-(trimethylammonio)propyl phosphate, 4-(methacrylolyloxy)butyl 3-(trimethylammonio)propyl phosphate, 5-(methacrylolyloxy)pentyl 3-(trimethylammonio)propyl phosphate, 6-(methacrylolyloxy)hexyl 3-(trimethylammonio)propyl phosphate, 7-(methacrylolyloxy)heptyl 3-(trimethylammonio)propyl phosphate, 8-(methacrylolyloxy)octyl 3-(trimethylammonio)propyl phosphate, 2-(methacrylolylamino)ethyl 3-(trimethylammonio)propyl phosphate, 3-(methacrylolylamino)propyl 3-(trimethylammonio)propyl phosphate, 4-(methacrylolylamino)butyl 3-(trimethylammonio)propyl phosphate, 5-(methacrylolylamino)pentyl 3-(trimethylammonio)propyl phosphate, 6-(methacrylolylamino)hexyl 3-(trimethylammonio)propyl phosphate, 7-(methacrylolylamino)heptyl 3-(trimethylammonio)propyl phosphate, 8-(methacrylolylamino)octyl 3-(trimethylammonio)propyl phosphate, 2-(acryloyloxy)ethyl 3-(trimethylammonio)propyl phosphate, 3-(acryloyloxy)propyl 3-(trimethylammonio)propyl phosphate, 4-(acryloyloxy)butyl 3-(trimethylammonio)propyl phosphate, 5-(acryloyloxy)pentyl 3-(trimethylammonio)propyl phosphate, 6-(acryloyloxy)hexyl 3-(trimethylammonio)propyl phosphate, 7-(acryloyloxy)heptyl 3-(trimethylammonio)propyl phosphate, 8-(acryloyloxy)octyl 3-(trimethylammonio)propyl phosphate, 2-(methacrylolyloxy)ethyl 4-(trimethylammonio)butyl phosphate, 3-(methacrylolyloxy)propyl 4-(trimethylammonio)butyl phosphate, 4-(methacrylolyloxy)butyl 4-(trimethylammonio)butyl phosphate, 5-(methacrylolyloxy)pentyl 4-(trimethylammonio)butyl phosphate, 6-(methacrylolyloxy)hexyl 4-(trimethylammonio)butyl phosphate, 7-(methacrylolyloxy)heptyl 4-(trimethylammonio)butyl phosphate, 8-(methacrylolyloxy)octyl 4-(trimethylammonio)butyl phosphate, 2-(methacrylolylamino)ethyl 4-(trimethylammonio)butyl phosphate, 3-(methacrylolylamino)propyl 4-(trimethylammonio)butyl phosphate, 4-(methacrylolylamino)butyl 4-(trimethylammonio)butyl phosphate, 5-(methacrylolylamino)pentyl 4-(trimethylammonio)butyl phosphate, 6-(methacrylolylamino)hexyl 4-(trimethylammonio)butyl phosphate, 7-(methacrylolylamino)heptyl 4-(trimethylammonio)butyl phosphate, 8-(methacrylolylamino)octyl 4-(trimethylammonio)butyl phosphate, 2-(acryloyloxy)ethyl 4-(trimethylammonio)butyl phosphate, 3-(acryloyloxy)propyl 4-(trimethylammonio)butyl phosphate, 4-(acryloyloxy)butyl 4-(trimethylammonio)butyl phosphate, 5-(acryloyloxy)pentyl 4-(trimethylammonio)butyl phosphate, 6-(acryloyloxy)hexyl 4-(trimethylammonio)butyl phosphate, 7-(acryloyloxy)heptyl 4-(trimethylammonio)butyl phosphate, and 8-(acryloyloxy)octyl 4-(trimethylammonio)butyl phosphate.

4. The reverse osmosis membrane of claim 1 , wherein the copolymer is prepared by reacting the amphoteric ionic compound and glycidyl (meth)acrylate by an equivalent ratio of 0.01 to 7:0.05 to 3.

5. The reverse osmosis membrane of claim 1 , wherein the copolymer further comprises ethylene glycol (meth)acrylate compound.

6. The reverse osmosis membrane of claim 5 , wherein the ethylene glycol (meth)acrylate compound is at least one selected from the group consisting of polyethylene glycol methacrylate, polyethylene glycol dimethacrylate and poly(ethylene glycol) methyl ether methacrylate.

7. The reverse osmosis membrane of claim 1 , wherein the coating layer includes a copolymer including the amphoteric ionic compound, glycidyl (meth)acrylate, poly(ethylene glycol) methacrylate and poly(ethylene glycol) dimethacrylate.

8. The reverse osmosis membrane of claim 6 , wherein the copolymer is prepared by reacting the amphoteric ionic compound, glycidyl (meth)acrylate, poly(ethylene glycol) methacrylate and poly(ethylene glycol) dimethacrylate by an equivalent ratio of 0.1 to 7.5:0.01 to 5:0.1 to 5:0.01 to 1.

9. The reverse osmosis membrane of claim 1 , wherein the reverse osmosis membrane has a salt rejection after 2 hours from an introduction of casein of 97% or more, and has a permeation flux of 23 to 25 gallon/ft 2 ·day.

10. A method of manufacturing a reverse osmosis membrane, comprising forming a coating layer by treating a porous support including a polyamide active layer with an aqueous solution including a copolymer including an amphoteric ionic compound and glycidyl (meth)acrylate; wherein the amphoteric ionic compound comprises one or more groups selected from the groups consisting of an ammonium group, a phosphonium group, a sulfonic acid group, a phosphate group and an acetate group.

11. The method of manufacturing a reverse osmosis membrane of claim 10 , wherein the aqueous solution comprises the copolymer by 0.0001 wt % to 10 wt %.

12. The method of manufacturing a reverse osmosis membrane of claim 10 , wherein the treating is conducted by a dipping process.

13. The method of manufacturing a reverse osmosis membrane of claim 12 , wherein the dipping process is conducted for 1 minute to 5 hours.

14. The method of manufacturing a reverse osmosis membrane of claim 10 , wherein the copolymer additionally comprises at least one of poly(ethylene glycol) methacrylate and poly(ethylene glycol) dimethacrylate.

15. The method of manufacturing a reverse osmosis membrane of claim 10 , further comprising preparing the copolymer by mixing the amphoteric ionic compound, glycidyl (meth)acrylate, poly(ethylene glycol) methacrylate and poly(ethylene glycol) dimethacrylate by an equivalent ratio of 0.1 to 7.5:0.01 to 5:0.1 to 5:0.01 to 1 and polymerizing.

16. The method of manufacturing a reverse osmosis membrane of claim 10 , further comprising drying at 25 to 65° C. for 1 to 30 minutes after forming the coating layer.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 24, 2025
From: LG CHEM, LTD.
To: NANOH2O CO., LTD.
Reel/Frame 073784/0326 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2013
From: JEONG, SEUNG-PYO; SHIN, CHONG-KYU
To: LG CHEM, LTD.
Reel/Frame 030898/0253 →
Priority Claims (2)
KR 10-2012-0001513 · Jan 5, 2012 · national
KR 10-2013-0000696 · Jan 3, 2013 · national
Continuity (2)
Continuation PCTKR2013000048 · Jan 4, 2013
Related Publication 20130306550A1 · Nov 21, 2013